Pipeline Flex embolisation device with Shield Technology for the treatment of patients with intracranial aneurysms: periprocedural and 6 month outcomes.
James YeomansLilian SanduAnand SastryPublished in: The neuroradiology journal (2020)
The Pipeline Shield has an excellent 6- month safety profile with an acceptable rate of intraprocedural complications, no post-procedure complications and no mortality in this case series of 32 acute and elective cases.
Keyphrases
- risk factors
- liver failure
- patients undergoing
- percutaneous coronary intervention
- respiratory failure
- minimally invasive
- cardiovascular disease
- type diabetes
- coronary artery disease
- direct oral anticoagulants
- intensive care unit
- acute coronary syndrome
- extracorporeal membrane oxygenation
- acute respiratory distress syndrome